Astiban therapy ofSchistosoma mansoniinfection: a quantitative evaluation
- 1 September 1967
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 61 (3) , 310-314
- https://doi.org/10.1080/00034983.1967.11686491
Abstract
(1967). Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation. Annals of Tropical Medicine & Parasitology: Vol. 61, No. 3, pp. 310-314.This publication has 8 references indexed in Scilit:
- Clinical trial with Ambilhar in Schistosoma mansoni infections in Tanzania.BMJ, 1966
- Astiban therapy of urinary schistosomiasis: a quantitative evaluationPathogens and Global Health, 1966
- Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania.BMJ, 1966
- Treatment of urinary schistosomiasis with Astiban and with Astiban acid in oil: a quantitative evaluationPathogens and Global Health, 1965
- TWSb inSchistosoma MansoniInfections: A Quantitative EvaluationPathogens and Global Health, 1964
- Sodium Antimony Dimercapto-Succinate (TWSb) in the Treatment of Human Schistosoma Mansoni InfectionsThe American Journal of Tropical Medicine and Hygiene, 1963
- A NEW METHOD FOR COUNTING SCHISTOSOMA MANSONI EGGS IN FAECES - WITH SPECIAL REFERENCE TO THERAPEUTIC TRIALS1963
- Treatment of Schistosomiasis Mansoni with Antimony-a, a′-Dimercapto-Potassium Succinate (TWSb)The American Journal of Tropical Medicine and Hygiene, 1954